H.Res. 1397

H.Res. 1397: Expressing support for the designation of June 28, 2026, as “Community is Stronger than Cancer Day”.

Introduced Debbie Wasserman Schultz (D) HOUSE_RESOLUTION — 119th Congress
Plain English Summary

H.Res. 1397 is a resolution expressing support for the designation of June 28, 2026, as 'Community is Stronger than Cancer Day.' The resolution aims to raise awareness about cancer and promote community support for those affected by the disease.

Positive Media Summary

The resolution has been positively received in media outlets that focus on health and community initiatives, highlighting the importance of unity and support in the fight against cancer. Advocates praise the designation as a way to foster awareness and encourage community engagement in cancer-related causes.

Negative Media Summary

Some critics argue that while the intention behind 'Community is Stronger than Cancer Day' is commendable, it may be seen as merely symbolic without concrete actions or funding for cancer research and support services. There are concerns that such resolutions do not address the systemic issues faced by cancer patients and survivors.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The bill H.Res. 1397 expresses support for a day recognizing community strength against cancer, which does not have direct financial ties to the sponsor's top donor industries. The primary lobbying activity in the healthcare sector, particularly from Vertex Pharmaceuticals, indicates some interest in cancer-related issues, but there is no direct financial overlap with the bill's subject matter. The total lobbying amounts from various organizations are substantial, but they do not directly influence the bill's intent or the sponsor's motivations. Therefore, the risk of conflict of interest appears minimal. Voters should be aware that while there are significant lobbying efforts in healthcare, they do not directly correlate with the sponsor's financial backers in this instance.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERTEX PHARMACEUTICALS INCORPORATED MARSHALL & POPP, LLC $60,000
SUN PHARMACEUTICAL INDUSTRIES, INC. MARSHALL & POPP, LLC $60,000
SANOFI U.S. SERVICES, INC. MARSHALL & POPP, LLC $60,000
WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) RED MAPLE CONSULTING, LLC $40,000
ECKERD CONNECTS KOUNTOUPES DENHAM CARR & REID, LLC $30,000
SMART APPROACHES TO MARIJUANA OFF HILL STRATEGIES L.L.C. $20,000
FEDERATION OF ELECTRIC POWER COS OF JAPAN GEORGE H. DENISON $10,000
MAYO CLINIC MCDERMOTT WILL & SCHULTE LLP undisclosed
VERIZON COMMUNICATIONS, INC. MARSHALL & POPP, LLC undisclosed
THE BIG TEN CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
THE BIG 12 CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
SOUTHEASTERN CONFERENCE MARSHALL & POPP, LLC undisclosed
PAC-12 CONFERENCE MARSHALL & POPP, LLC undisclosed
ATLANTIC COAST CONFERENCE MARSHALL & POPP, LLC undisclosed
SAPPHIRE DIGITAL MARSHALL & POPP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Debbie Wasserman Schultz, ranked by total contributions.

Health Professionals $600,000,000
Individuals: $600,000,000 PACs: $0
Retired $187,500,000
Individuals: $187,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us